The U.S. Food and Drug Administration has approved new product strengths for Octapharma’s NUWIQ.
A clinical trial comparing the protective efficacy in older adults of a quadrivalent recombinant influenza vaccine with a standard-dose, egg-grown quadrivalent inactivated influenza vaccine during the A/H3N2-predominant 2014-2015 influenza season showed RIV4 provided better protection against confirmed influenza-like illness among older adults.
The Agency for Healthcare Research and Quality has released a preliminary update to the National Scorecard on Rates ofHospital-Acquired Conditions that show a 21 percent reduction in hospital-acquired conditions from 2010 to 2015.
The Centers for Medicare and Medicaid would exempt physician practices with less than $90,000 in Medicare revenue or fewer than 200 unique Medicare patients per year from complying with the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.
Sanofi Pasteur has acquired Protein Sciences, a privately held vaccines biotechnology company based inMeriden, Conn.
A new study shows that microneedle patches provide an alternative to conventional needle-and-syringe immunization, potentially offering improved immunogenicity, simplicity, cost-effectiveness, acceptability and safety.
A multidisciplinary team of investigators based in New Delhi randomized 120 patients with liver cirrhosis and overt hepatic encephalopathy (HE) to receive oral lactulose therapy or oral lactulose plus 1.5 g/kg/day of human albumin. The primary study endpoint was complete reversal of HE; secondary endpoints included mortality and length of hospital stay.
A study conducted at the University of British Columbia found that mothers are viewed negatively if their child hasn’t been vaccinated, regardless of the reason.
The National Institutes of Health has awarded a $3 million grant to Feinstein Institute for Medical Research scientists to study the relationship between a mother’s autoimmunity during pregnancy and the risk of autism spectrum disorder in her child.
A new study conducted at the Boston Medical Center is the first to support new recommendations for a two-dose HPV vaccine to prevent genital warts in kids younger than 15 years old.
The U.S. Department of Health and Human Services has officially changed the name of AIDS.gov, the federal government’s source for information about HIV, to HIV.gov.
ADMA Biologics, which develops, manufactures and commercializes specialty plasma-based biologics for the treatment of immune deficiencies and prevention of certain infectious diseases, has acquired Biotest Pharmaceuticals’ Therapy Business Unit.
